| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $212K | +0.0% | -29.1% |
| R&D Expense | $4.1M | -31.8% | -49.7% |
| SG&A Expense | $3.0M | -28.6% | -27.4% |
| Operating Income | -$6.9M | +31.1% | +42.6% |
| Pre-tax Income | $16.0M | +270.1% | +247.9% |
| Net Income | $16.0M | +265.1% | +239.7% |
| EPS (Basic) | $0.36 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.1M | +240.1% | +26.9% |
| Short-term Investments | $27.2M | -25.1% | -45.4% |
| Current Assets | $66.6M | +32.6% | -14.8% |
| Total Assets | $67.7M | +32.7% | -14.4% |
| Current Liabilities | $4.5M | -10.3% | -44.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.1M | — | — |
| Investing Cash Flow | $43.3M | — | — |
| Financing Cash Flow | $10K | — | — |
| +263.6% |
| +238.5% |
| EPS (Diluted) | $0.36 | +263.6% | +238.5% |
| $4.6M |
| -8.2% |
| -43.5% |
| Stockholders' Equity | $63.0M | +37.1% | -11.0% |